{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:10:47Z","timestamp":1778602247575,"version":"3.51.4"},"reference-count":45,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jcim-2025-0277_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Medicinal cannabis (MC) has recently been legalized in a growing number of countries. While MC is considered a potentially safe alternative or add-on to conventional treatments for pain, spasms, neuropathy, and chemotherapy-induced nausea\/vomiting, evidence of its effectiveness and safety remains limited. This study aimed to assess patients\u2019 perceived benefits and side effects of MC and explore patterns in side effect experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0277_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a Danish nationwide online survey in 2020 among two groups of MC users: one with predefined diagnostic indications (neuropathic pain, chemotherapy-induced nausea\/vomiting, or painful spasms from multiple sclerosis\/paraplegia) (n=258) and one with other indications (n=786). Perceived benefit and side effects were measured using self-reported responses. We compared perceived benefit to the number of side effects and used a heat plot correlation matrix and exploratory factor analysis to identify patterns. Predicted factor scores were used to compare perceived benefit relative to side effect profiles, stratified by indication\u00a0group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0277_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most patients (67\u202f%) reported a moderate to large effect of MC. Over half experienced side effects, with more than 10\u202f% reporting three or more. Side effects were equally common among patients reporting a moderate to large vs. no to minor effect (p=0.27 and 0.68 for predefined and other indications). Side effects clustered into four groups: cognitive dysfunction, dizziness, xerostomia, and feeling \u201chigh\u201d. These were not related to perceived benefit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2025-0277_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most patients reported a moderate to large effect from MC. Over one in ten experienced three or more side effects, which were unrelated to perceived treatment effect.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2025-0277","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:57:38Z","timestamp":1764683858000},"page":"179-189","source":"Crossref","is-referenced-by-count":0,"title":["Patients\u2019 perceived benefit and side effects from the use of medicinal cannabis\u00a0\u2013\u00a0a cross-sectional survey study from Denmark"],"prefix":"10.1515","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0214-1539","authenticated-orcid":false,"given":"Frederik","family":"Rosenb\u00e6k","sequence":"first","affiliation":[{"name":"Research Unit of General Practice, Department of Public Health , University of Southern Denmark , Odense M , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-2045","authenticated-orcid":false,"given":"Line Bj\u00f8rnskov","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Research Unit of General Practice, Department of Public Health , University of Southern Denmark , Odense M , Denmark"},{"name":"Department of Public Health , DaCHE\u00a0\u2013\u00a0Danish Centre for Health Economics, University of Southern Denmark , Odense M , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1503-2649","authenticated-orcid":false,"given":"Sonja","family":"Wehberg","sequence":"additional","affiliation":[{"name":"Research Unit of General Practice, Department of Public Health , University of Southern Denmark , Odense M , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5764-5462","authenticated-orcid":false,"given":"Jesper Bo","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Research Unit of General Practice, Department of Public Health , University of Southern Denmark , Odense M , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1629-1864","authenticated-orcid":false,"given":"Jens","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[{"name":"Research Unit of General Practice, Department of Public Health , University of Southern Denmark , Odense M , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"2026051215162679017_j_jcim-2025-0277_ref_001","doi-asserted-by":"crossref","unstructured":"Pisanti, S, Bifulco, M. Medical cannabis: a plurimillennial history of an evergreen. J\u00a0Cell Physiol 2019;234:8342\u201351. https:\/\/doi.org\/10.1002\/jcp.27725.","DOI":"10.1002\/jcp.27725"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_002","doi-asserted-by":"crossref","unstructured":"Bonini, SA, Premoli, M, Tambaro, S, Kumar, A, Maccarinelli, G, Memo, M, et al.. Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history. J\u00a0Ethnopharmacol 2018;227:300\u201315. https:\/\/doi.org\/10.1016\/j.jep.2018.09.004.","DOI":"10.1016\/j.jep.2018.09.004"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_003","unstructured":"National Conference of State Legislatures. State medical cannabis laws: national conference of state legislatures; 2024. Available from: https:\/\/www.ncsl.org\/health\/state-medical-cannabis-laws."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_004","unstructured":"Magrabi, T. A guide to medical marijuana legalization around the world: Leafwell; 2024. Available from: https:\/\/leafwell.com\/blog\/countries-where-weed-is-legal."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_005","unstructured":"Ram\u00edrez, T. Medicinal cannabis policies and practices around the world. Mexico City: United Nations Office on Drugs and Crime; 2019."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_006","unstructured":"Shakil, N. 2025 Cannabis policy reform legislation: what advocates need to know: leafy mate; 2025 Available from: https:\/\/leafymate.com\/resources\/advocacy-and-legislation\/2025-cannabis-policy-reform."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_007","unstructured":"Marijuana Policy Project. Cannabis policy reform legislation and voter measures 2025; 2025. Available from: https:\/\/www.mpp.org\/issues\/legislation\/key-marijuana-policy-reform\/."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_008","doi-asserted-by":"crossref","unstructured":"Barakji, J, Korang, SK, Feinberg, J, Maagaard, M, Mathiesen, O, Gluud, C, et al.. Cannabinoids versus placebo for pain: a systematic review with meta-analysis and trial sequential analysis. PLoS One 2023;18:e0267420. https:\/\/doi.org\/10.1371\/journal.pone.0267420.","DOI":"10.1371\/journal.pone.0267420"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_009","doi-asserted-by":"crossref","unstructured":"McParland, AL, Bhatia, A, Matelski, J, Tian, C, Diep, C, Clarke, H, et al.. Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. Reg Anesth Pain Med 2023;48:180\u201390. https:\/\/doi.org\/10.1136\/rapm-2021-103431.","DOI":"10.1136\/rapm-2021-103431"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_010","doi-asserted-by":"crossref","unstructured":"Smith, LA, Azariah, F, Lavender, VT, Stoner, NS, Bettiol, S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev 2015;2015:Cd009464. https:\/\/doi.org\/10.1002\/14651858.CD009464.pub2.","DOI":"10.1002\/14651858.CD009464.pub2"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_011","doi-asserted-by":"crossref","unstructured":"Lim, K, See, YM, Lee, J. A systematic review of the effectiveness of medical cannabis for psychiatric, movement and neurodegenerative disorders. Clin Psychopharmacol Neurosci 2017;15:301\u201312. https:\/\/doi.org\/10.9758\/cpn.2017.15.4.301.","DOI":"10.9758\/cpn.2017.15.4.301"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_012","doi-asserted-by":"crossref","unstructured":"Martinez-Paz, C, Garc\u00eda-Cabrera, E, Vilches-Arenas, \u00c1. Effectiveness and safety of cannabinoids as an add-on therapy in the treatment of resistant spasticity in multiple sclerosis: a systematic review. Cannabis Cannabinoid Res 2023;8:580\u20138. https:\/\/doi.org\/10.1089\/can.2022.0254.","DOI":"10.1089\/can.2022.0254"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_013","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) adopts consolidated guideline on good clinical practice in the conduct of clinical trials on medicinal products for human use. Int Dig Health Legis 1997;48:231\u20134."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_014","unstructured":"N\u00f8rby, ET. Lov om fors\u00f8gsordning med medicinsk cannabis: Danish Ministry of Health; 2017. Available from: https:\/\/www.retsinformation.dk\/eli\/lta\/2017\/1668."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_015","unstructured":"Danish Medicines Agency. Medicinal cannabis pilot programme: Danish Medicines Agency; 2022. Available from: https:\/\/laegemiddelstyrelsen.dk\/en\/special\/medicinal-cannabis-\/medicinal-cannabis-pilot-programme\/."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_045","doi-asserted-by":"crossref","unstructured":"World Medical Association. World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191\u20134.","DOI":"10.1001\/jama.2013.281053"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_016","doi-asserted-by":"crossref","unstructured":"Potteg\u00e5rd, A, Schmidt, SAJ, Wallach-Kildemoes, H, S\u00f8rensen, HT, Hallas, J, Schmidt, M. Data resource profile: the Danish National Prescription Registry. Int J Epidemiol 2017;46:798\u2013f. https:\/\/doi.org\/10.1093\/ije\/dyw213.","DOI":"10.1093\/ije\/dyw213"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_017","doi-asserted-by":"crossref","unstructured":"Schmidt, M, Schmidt, SA, Sandegaard, JL, Ehrenstein, V, Pedersen, L, Sorensen, HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015;7:449\u201390. https:\/\/doi.org\/10.2147\/clep.s91125.","DOI":"10.2147\/CLEP.S91125"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_018","unstructured":"StataCorp. Stata statistical software: release 18. College Station, TX: StataCorp LLC; 2023."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_019","unstructured":"Covidence. Covidence template aligning with PRISMA 2020 for a systematic literature review; 2023. Available from: https:\/\/support.covidence.org\/help\/prisma-flow-diagram."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_020","unstructured":"Amato, L, Minozzi, S, Mitrova, Z, Parmelli, E, Saulle, R, Cruciani, F, et al.. Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy. Epidemiol Prev 2017;41:279\u201393. https:\/\/doi.org\/10.19191\/EP17.5-6.AD01.069."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_021","doi-asserted-by":"crossref","unstructured":"Stockings, E, Campbell, G, Hall, WD, Nielsen, S, Zagic, D, Rahman, R, et al.. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain 2018;159:1932\u201354. https:\/\/doi.org\/10.1097\/j.pain.0000000000001293.","DOI":"10.1097\/j.pain.0000000000001293"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_022","doi-asserted-by":"crossref","unstructured":"H\u00e4user, W, Welsch, P, Klose, P, Radbruch, L, Fitzcharles, MA. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain: a systematic review with meta-analysis of randomised controlled trials. Schmerz 2019;33:424\u201336. https:\/\/doi.org\/10.1007\/s00482-019-0373-3.","DOI":"10.1007\/s00482-019-0373-3"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_023","doi-asserted-by":"crossref","unstructured":"de Carvalho Reis, R, Almeida, KJ, da Silva Lopes, L, de Melo Mendes, CM, Bor-Seng-Shu, E. Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: systematic review and meta-analysis. Epilepsy Behav 2020;102:106635. https:\/\/doi.org\/10.1016\/j.yebeh.2019.106635.","DOI":"10.1016\/j.yebeh.2019.106635"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_024","doi-asserted-by":"crossref","unstructured":"Wang, L, Hong, PJ, May, C, Rehman, Y, Oparin, Y, Hong, CJ, et al.. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ 2021;374:n1034. https:\/\/doi.org\/10.1136\/bmj.n1034.","DOI":"10.1136\/bmj.n1034"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_025","doi-asserted-by":"crossref","unstructured":"AminiLari, M, Wang, L, Neumark, S, Adli, T, Couban, RJ, Giangregorio, A, et al.. Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials. Sleep 2022;45. https:\/\/doi.org\/10.1093\/sleep\/zsab234.","DOI":"10.1093\/sleep\/zsab234"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_026","doi-asserted-by":"crossref","unstructured":"H\u00e4user, W, Welsch, P, Radbruch, L, Fisher, E, Bell, RF, Moore, RA. Cannabis-based medicines and medical cannabis for adults with cancer pain. Cochrane Database Syst Rev 2023;6:Cd014915. https:\/\/doi.org\/10.1002\/14651858.CD014915.pub2.","DOI":"10.1002\/14651858.CD014915.pub2"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_027","doi-asserted-by":"crossref","unstructured":"Micha, JP, Rettenmaier, MA, Bohart, RD, Goldstein, BH. Medical marijuana in the treatment of cancer-associated symptoms. J\u00a0Oncol Pharm Pract 2024;30:1240\u20134. https:\/\/doi.org\/10.1177\/10781552241262963.","DOI":"10.1177\/10781552241262963"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_028","doi-asserted-by":"crossref","unstructured":"Gedin, F, Blom\u00e9, S, Pont\u00e9n, M, Lalouni, M, Fust, J, Raquette, A, et al.. Placebo response and media attention in randomized clinical trials assessing cannabis-based therapies for pain: a systematic review and meta-analysis. JAMA Netw Open 2022;5:e2243848. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.43848.","DOI":"10.1001\/jamanetworkopen.2022.43848"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_029","doi-asserted-by":"crossref","unstructured":"Sexton, M, Garcia, JM, Jatoi, A, Clark, CS, Wallace, MS. The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids. J\u00a0Natl Cancer Inst Monogr 2021;2021:86\u201398. https:\/\/doi.org\/10.1093\/jncimonographs\/lgab011.","DOI":"10.1093\/jncimonographs\/lgab011"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_030","doi-asserted-by":"crossref","unstructured":"Castle, RD, Marzolf, J, Morris, M, Bushell, WC. Meta-analysis of medical cannabis outcomes and associations with cancer. Front Oncol 2025;15:1\u201323. https:\/\/doi.org\/10.3389\/fonc.2025.1490621.","DOI":"10.3389\/fonc.2025.1490621"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_031","doi-asserted-by":"crossref","unstructured":"Whiting, PF, Wolff, RF, Deshpande, S, Di Nisio, M, Duffy, S, Hernandez, AV, et al.. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015;313:2456\u201373. https:\/\/doi.org\/10.1001\/jama.2015.6358.","DOI":"10.1001\/jama.2015.6358"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_032","unstructured":"Danish Medicines Agency. Bivirkningsindberetninger om cannabisslutprodukter og forbrug under fors\u00f8gsordningen 1. January\u00a0\u2013\u00a031. December 2020; 2021."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_033","unstructured":"Danish Medicines Agency. Bivirkningsindberetninger om cannabisslutprodukter og forbrug under fors\u00f8gsordningen 1. January\u00a0\u2013\u00a031. December 2019. Copenhagen; 2020."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_034","unstructured":"Danish Medicines Agency. Bivirkningsindberetninger om cannabisslutprodukter og forbrug under fors\u00f8gsordningen. Copenhagen: Danish Medicines Agency; 2020."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_035","unstructured":"Danish Medicines Agency. Bivirkningsindberetninger om cannabisslutprodukter under fors\u00f8gsordningen 1. January\u00a0\u2013\u00a031. December 2018. Copenhagen; 2019."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_036","unstructured":"Danish Medicines Agency. Bivirkningsindberetninger om cannabisslutprodukter og forbrug under fors\u00f8gsordningen 1. January 2021\u00a0\u2013\u00a031. December 2022; 2023."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_037","unstructured":"Danish Medicines Agency. Bivirkningsindberetninger om cannabisslutprodukter og forbrug under fors\u00f8gsordningen 1. January\u00a0\u2013\u00a031. December 2023. Copenhagen; 2024."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_038","unstructured":"Danish Ministry of Health. Evaluering af fors\u00f8gsordningen med medicinsk cannabis. Copenhagen; 2020."},{"key":"2026051215162679017_j_jcim-2025-0277_ref_039","doi-asserted-by":"crossref","unstructured":"Schlienz, NJ, Scalsky, R, Martin, EL, Jackson, H, Munson, J, Strickland, JC, et al.. A cross-sectional and prospective comparison of medicinal cannabis users and controls on self-reported health. Cannabis Cannabinoid Res 2021;6:548\u201358. https:\/\/doi.org\/10.1089\/can.2019.0096.","DOI":"10.1089\/can.2019.0096"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_040","doi-asserted-by":"crossref","unstructured":"Martin, EL, Strickland, JC, Schlienz, NJ, Munson, J, Jackson, H, Bonn-Miller, MO, et al.. Antidepressant and anxiolytic effects of medicinal cannabis use in an observational trial. Front Psychiatr 2021;12. https:\/\/doi.org\/10.3389\/fpsyt.2021.729800.","DOI":"10.3389\/fpsyt.2021.729800"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_041","doi-asserted-by":"crossref","unstructured":"Infante-Rivard, C, Cusson, A. Reflection on modern methods: selection bias\u00a0\u2013\u00a0a review of recent developments. Int J Epidemiol 2018;47:1714\u201322. https:\/\/doi.org\/10.1093\/ije\/dyy138.","DOI":"10.1093\/ije\/dyy138"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_042","doi-asserted-by":"crossref","unstructured":"Bethlehem, J. Selection bias in web surveys. Int Stat Rev\/Rev Int Stat 2010;78:161\u201388. https:\/\/doi.org\/10.1111\/j.1751-5823.2010.00112.x.","DOI":"10.1111\/j.1751-5823.2010.00112.x"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_043","doi-asserted-by":"crossref","unstructured":"Rasheed, SH. Ensuring safety and monitoring adverse events in clinical trials: challenges and innovations. WJBPHS 2024;20:454\u20137. https:\/\/doi.org\/10.30574\/wjbphs.2024.20.1.0798.","DOI":"10.30574\/wjbphs.2024.20.1.0798"},{"key":"2026051215162679017_j_jcim-2025-0277_ref_044","doi-asserted-by":"crossref","unstructured":"Colombo, D, Suso-Ribera, C, Fern\u00e1ndez-\u00c1lvarez, J, Cipresso, P, Garcia-Palacios, A, Riva, G, et al.. Affect recall bias: being resilient by distorting reality. Cognit Ther Res 2020;44:906\u201318.","DOI":"10.1007\/s10608-020-10122-3"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0277\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0277\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:28:26Z","timestamp":1778599706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2025-0277\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,29]]},"published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1515\/jcim-2025-0277"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2025-0277","relation":{},"ISSN":["2194-6329","1553-3840"],"issn-type":[{"value":"2194-6329","type":"print"},{"value":"1553-3840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}